Stay updated on ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Sign up to get notified when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.

Latest updates to the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe webpage has been updated to include new information about the clinical study of ADVM-022 for wet age-related macular degeneration, including a new version revision and details about the study's design. However, significant content regarding the treatment's background and implications has been removed.SummaryDifference26%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.